Evidence map›Paper›PMID 28443214›Full record

ArticleSpringerPlus2016

Prevalence and risk factors of methicillin-resistant

Goyitom Gebremedhn, Tewelde Tesfay Gebremariam, Araya Gebreyesus Wasihun, Tsehaye Asmelash Dejene, Muthupandian Saravanan

Abstract read
In one paragraph

Article in SpringerPlus, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed, 5 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 5 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Risk factors for methicillin-resistantThe Journal of international medical research · 2022
    Pooled it
  5. Pooled it
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Risk factors of methicillin-resistantFrontiers in microbiology · 2025
    Article
  12. Article
  13. NasopharyngealAccess microbiology · 2023
    Article
  14. Antimicrobial Resistance Patterns ofInfection and drug resistance · 2023
    Article
  15. Review
  16. Article
  17. Methicillin-resistantIJID regions · 2022
    Article
  18. Methicillin-resistantFuture science OA · 2022
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Goyitom GebremedhnDepartment of Medical Microbiology and Immunology, Institute of Biomedical Science, College of Health Sciences, Mekelle University, 1871 Mekelle, Ethiopia.
Tewelde Tesfay GebremariamDepartment of Medical Microbiology and Immunology, Institute of Biomedical Science, College of Health Sciences, Mekelle University, 1871 Mekelle, Ethiopia.
Araya Gebreyesus WasihunDepartment of Medical Microbiology and Immunology, Institute of Biomedical Science, College of Health Sciences, Mekelle University, 1871 Mekelle, Ethiopia.
Tsehaye Asmelash DejeneDepartment of Medical Microbiology and Immunology, Institute of Biomedical Science, College of Health Sciences, Mekelle University, 1871 Mekelle, Ethiopia.
Muthupandian SaravananDepartment of Medical Microbiology and Immunology, Institute of Biomedical Science, College of Health Sciences, Mekelle University, 1871 Mekelle, Ethiopia.ORCID 0000-0002-1480-3555

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

HIV-positive individuals are at higher risk of Methicillin Resistant

Indexed as

CD4 countHIV patientsMRSAPrevalenceRisk factorsS. aureus

Identifiers

PMID28443214
PMCPMC5396476

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.